3/2
01:59 pm
acad
Wolfe Research Notes Conviction-Driven Opportunities in ACADIA Pharmaceuticals Inc.'s (ACAD) Therapeutic Domains [Yahoo! Finance]
Neutral
Report
Wolfe Research Notes Conviction-Driven Opportunities in ACADIA Pharmaceuticals Inc.'s (ACAD) Therapeutic Domains [Yahoo! Finance]
2/28
09:08 am
acad
Acadia Pharmaceuticals: Undervalued Despite Robust Revenues From Approved Drugs, With Pipeline Kicker [Seeking Alpha]
Medium
Report
Acadia Pharmaceuticals: Undervalued Despite Robust Revenues From Approved Drugs, With Pipeline Kicker [Seeking Alpha]
2/26
12:53 pm
acad
ACADIA Pharmaceuticals (ACAD) had its price target raised by TD Cowen from $35.00 to $37.00. They now have a "buy" rating on the stock.
Medium
Report
ACADIA Pharmaceuticals (ACAD) had its price target raised by TD Cowen from $35.00 to $37.00. They now have a "buy" rating on the stock.
2/26
10:30 am
acad
ACADIA Pharmaceuticals (ACAD) had its price target lowered by Royal Bank Of Canada from $31.00 to $30.00. They now have an "outperform" rating on the stock.
Low
Report
ACADIA Pharmaceuticals (ACAD) had its price target lowered by Royal Bank Of Canada from $31.00 to $30.00. They now have an "outperform" rating on the stock.
2/26
09:55 am
acad
ACADIA Pharmaceuticals (ACAD) had its price target raised by Citizens Jmp from $34.00 to $35.00. They now have a "market outperform" rating on the stock.
Low
Report
ACADIA Pharmaceuticals (ACAD) had its price target raised by Citizens Jmp from $34.00 to $35.00. They now have a "market outperform" rating on the stock.
2/26
09:26 am
acad
ACADIA Pharmaceuticals (ACAD) had its price target lowered by Stifel Nicolaus from $25.00 to $24.00. They now have a "hold" rating on the stock.
Low
Report
ACADIA Pharmaceuticals (ACAD) had its price target lowered by Stifel Nicolaus from $25.00 to $24.00. They now have a "hold" rating on the stock.
2/26
12:42 am
acad
ACADIA Pharmaceuticals Inc (ACAD) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
Low
Report
ACADIA Pharmaceuticals Inc (ACAD) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
2/25
06:58 pm
acad
ACADIA (ACAD) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
ACADIA (ACAD) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
2/25
06:41 pm
acad
ACADIA Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
ACADIA Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
2/25
04:05 pm
acad
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operating Overview
Low
Report
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operating Overview
2/25
06:24 am
acad
ACADIA Pharmaceuticals (ACAD) was upgraded by Wolfe Research to "strong-buy".
Low
Report
ACADIA Pharmaceuticals (ACAD) was upgraded by Wolfe Research to "strong-buy".
2/24
09:42 am
acad
Assessing ACADIA Pharmaceuticals (ACAD) Valuation After Analyst Upgrades And Pipeline Expansion Optimism [Yahoo! Finance]
Low
Report
Assessing ACADIA Pharmaceuticals (ACAD) Valuation After Analyst Upgrades And Pipeline Expansion Optimism [Yahoo! Finance]
2/23
06:01 pm
acad
ACADIA Pharmaceuticals (NASDAQ:ACAD) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Low
Report
ACADIA Pharmaceuticals (NASDAQ:ACAD) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
2/23
04:24 pm
acad
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences [Yahoo! Finance]
2/23
04:05 pm
acad
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
Low
Report
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
2/23
07:17 am
acad
ACADIA Pharmaceuticals (NASDAQ:ACAD) was given a new $35.00 price target on by analysts at Mizuho.
Low
Report
ACADIA Pharmaceuticals (NASDAQ:ACAD) was given a new $35.00 price target on by analysts at Mizuho.
2/18
01:05 am
acad
Oppenheimer Maintains A Balanced Outlook on ACADIA Pharmaceuticals Inc. (ACAD) For 2026 [Yahoo! Finance]
Low
Report
Oppenheimer Maintains A Balanced Outlook on ACADIA Pharmaceuticals Inc. (ACAD) For 2026 [Yahoo! Finance]
2/6
12:44 pm
acad
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $21.00 to $23.00. They now have a "market perform" rating on the stock.
Low
Report
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $21.00 to $23.00. They now have a "market perform" rating on the stock.
2/6
08:43 am
acad
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "market perform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Low
Report
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "market perform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
2/4
04:27 pm
acad
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 [Yahoo! Finance]
Medium
Report
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 [Yahoo! Finance]
2/4
04:05 pm
acad
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
Medium
Report
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
2/3
01:07 pm
acad
Exploring US High Growth Tech Stocks This February 2026 [Yahoo! Finance]
Low
Report
Exploring US High Growth Tech Stocks This February 2026 [Yahoo! Finance]
2/3
11:33 am
acad
Acadia Pharmaceuticals' Rett Syndrome Medication Less Likely to Receive EU Approval, RBC Says [Yahoo! Finance]
Low
Report
Acadia Pharmaceuticals' Rett Syndrome Medication Less Likely to Receive EU Approval, RBC Says [Yahoo! Finance]
2/3
09:11 am
acad
ACADIA Pharmaceuticals (NASDAQ:ACAD) was given a new $31.00 price target on by analysts at Royal Bank Of Canada.
Medium
Report
ACADIA Pharmaceuticals (NASDAQ:ACAD) was given a new $31.00 price target on by analysts at Royal Bank Of Canada.
2/3
08:44 am
acad
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "market outperform" rating reaffirmed by analysts at Citizens Jmp. They now have a $34.00 price target on the stock.
Medium
Report
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "market outperform" rating reaffirmed by analysts at Citizens Jmp. They now have a $34.00 price target on the stock.